32-country study shows that type 2 diabetes drug is clinically effective for long-term use (AlphaGalileo, 23 July 2012)

24 Jul 2012


A multi-national collaborative study published in the International Journal of Clinical Practice examines the safety and efficacy of the oral DPP-4 inhibitor linagliptin in type 2 diabetes.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story